Analysts think NRXP stock price could increase by 1150%
May 11, 2025, 11:26 AM
80.15%
What does NRXP do
NRX Pharmaceuticals, headquartered in Wilmington, Delaware, is a clinical-stage biopharmaceutical company specializing in treatments for central nervous system disorders, including its lead compounds NRX-100 and NRX-101. The company went public on November 20, 2017, and is developing therapies targeting bipolar depression, chronic pain, and PTSD.
6 analysts think NRXP stock price will increase by 1150.00%. The current median analyst target is $25.50 compared to a current stock price of $2.04. The lowest analysts target is $18.18 and the highest analyst target is $48.30.
📡️ Health Care
Price Target
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.